Legal Cannabis Market Size, Share & Trends Analysis Report By Source (Marijuana, Hemp), By Derivative (CBD, THC), By End Use (Medical Use, Recreational Use, Industrial Use), By Region, And Segment Forecasts, 2025 - 2033
Description
Legal Cannabis Market Summary
The global legal cannabis market size was estimated at USD 69.78 billion in 2024 and is projected to reach USD 216.76 billion by 2033, growing at a CAGR of 13.49% from 2025 to 2033. The rising global prevalence of chronic diseases, particularly cancer, is accelerating the adoption of medical marijuana.
According to the National Cancer Institute article published in May 2025,cancer alone accounted for nearly 20 million new cases and 9.7 million deaths worldwide in 2022, with projections indicating these numbers will rise to 33 million cases and 18.2 million deaths annually by 2050. This growing patient pool drives the demand for alternative and complementary therapies to manage symptoms and improve quality of life. Medical marijuana has gained recognition for its potential in alleviating cancer-related pain, reducing chemotherapy-induced nausea, stimulating appetite, and supporting palliative care. While more countries legalize cannabis for medical use, the increasing cancer burden is expected to be a significant aspect of the growth of the legal cannabis market.
The cannabis sector is experiencing rapid growth due to the expanding acceptance of cannabis for both medicinal and recreational purposes. In many U.S. states, legalization currently applies primarily to medical use, with broader adult-use legalization expected in the coming years. Such measures aim to reduce the impact of the illegal marijuana market while enabling governments to generate significant tax revenue from regulated cannabis sales. For example, in fiscal year 2023, Washington state reported USD 468.5 million in revenue from legal cannabis sales and licensing fees.
The adoption of cannabis is anticipated to increase further with the growing number of medical and adult-use patients & customers. Furthermore, with the legalization of marijuana for adult use, a shift in patient preference for marijuana from medical to recreational purposes is anticipated due to the low cost and easy access to marijuana after legalization in the state. For instance, Delaware and Minnesota legalized cannabis for recreational/adult use in April 2023 and August 2023, respectively.
The cannabis industry is highly regulated, and the use of cannabis for medical purposes is still considered illegal in several states in the U.S. Cannabis is legalized in the majority of U.S. states and continuous political movements are supporting its legalization for medical and recreational purposes across several other states in the U.S. Furthermore, various other states are expected to follow suit, which is anticipated to fuel market growth. For instance, in March 2023, the state of Kentucky in the U.S. legalized cannabis for medical purposes.
Furthermore, rising awareness of cannabis's therapeutic benefits and the launch of cannabis certification programs through partnerships drive market growth. For instance, in December 2023, Bellarmine University introduced a cannabis education certificate program offered by a public Kentucky university focusing on agriculture, business, medicine, and law in the fast-changing cannabis industry.
Global Legal Cannabis Market Report Segmentation
This report forecasts revenue and volume growth at global, regional, and country levels and analyzes industry trends in each sub-segments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the legal cannabis market report based on source, derivative, end use, and region:
The global legal cannabis market size was estimated at USD 69.78 billion in 2024 and is projected to reach USD 216.76 billion by 2033, growing at a CAGR of 13.49% from 2025 to 2033. The rising global prevalence of chronic diseases, particularly cancer, is accelerating the adoption of medical marijuana.
According to the National Cancer Institute article published in May 2025,cancer alone accounted for nearly 20 million new cases and 9.7 million deaths worldwide in 2022, with projections indicating these numbers will rise to 33 million cases and 18.2 million deaths annually by 2050. This growing patient pool drives the demand for alternative and complementary therapies to manage symptoms and improve quality of life. Medical marijuana has gained recognition for its potential in alleviating cancer-related pain, reducing chemotherapy-induced nausea, stimulating appetite, and supporting palliative care. While more countries legalize cannabis for medical use, the increasing cancer burden is expected to be a significant aspect of the growth of the legal cannabis market.
The cannabis sector is experiencing rapid growth due to the expanding acceptance of cannabis for both medicinal and recreational purposes. In many U.S. states, legalization currently applies primarily to medical use, with broader adult-use legalization expected in the coming years. Such measures aim to reduce the impact of the illegal marijuana market while enabling governments to generate significant tax revenue from regulated cannabis sales. For example, in fiscal year 2023, Washington state reported USD 468.5 million in revenue from legal cannabis sales and licensing fees.
The adoption of cannabis is anticipated to increase further with the growing number of medical and adult-use patients & customers. Furthermore, with the legalization of marijuana for adult use, a shift in patient preference for marijuana from medical to recreational purposes is anticipated due to the low cost and easy access to marijuana after legalization in the state. For instance, Delaware and Minnesota legalized cannabis for recreational/adult use in April 2023 and August 2023, respectively.
The cannabis industry is highly regulated, and the use of cannabis for medical purposes is still considered illegal in several states in the U.S. Cannabis is legalized in the majority of U.S. states and continuous political movements are supporting its legalization for medical and recreational purposes across several other states in the U.S. Furthermore, various other states are expected to follow suit, which is anticipated to fuel market growth. For instance, in March 2023, the state of Kentucky in the U.S. legalized cannabis for medical purposes.
Furthermore, rising awareness of cannabis's therapeutic benefits and the launch of cannabis certification programs through partnerships drive market growth. For instance, in December 2023, Bellarmine University introduced a cannabis education certificate program offered by a public Kentucky university focusing on agriculture, business, medicine, and law in the fast-changing cannabis industry.
Global Legal Cannabis Market Report Segmentation
This report forecasts revenue and volume growth at global, regional, and country levels and analyzes industry trends in each sub-segments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the legal cannabis market report based on source, derivative, end use, and region:
- Source Outlook (Revenue USD Million, 2021 - 2033)
- Marijuana
- Flowers
- Oil and Tinctures
- Hemp
- Hemp CBD
- Industrial Hemp
- Derivative Outlook (Revenue USD Million, 2021 - 2033)
- CBD
- THC
- Others
- End-Use Outlook (Revenue USD Million, 2021 - 2033)
- Medical Use
- Cancer
- Chronic Pain
- Depression and Anxiety
- Arthritis
- Diabetes
- Glaucoma
- Migraines
- Epilepsy
- Multiple Sclerosis
- AIDS
- Amyotrophic Lateral Sclerosis
- Alzheimer’s
- Post-Traumatic Stress Disorder (PTSD)
- Parkinson's
- Tourette’s
- Others
- Recreational Use
- Industrial Use
- Regional Outlook Revenue USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- Italy
- Poland
- Czech Republic
- Switzerland
- Croatia
- Netherlands
- Spain
- Asia
- China
- Japan
- India
- Thailand
- Oceania
- Australia
- New Zealand
- Latin America
- Brazil
- Mexico
- Uruguay
- Colombia
- Africa
Table of Contents
150 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Regional Scope
- 1.3. Estimates and Forecast Timeline
- 1.4. Objectives
- 1.5. Research Methodology
- 1.6. Information Procurement
- 1.6.1. Purchased Database
- 1.6.2. GVR’s Internal Database
- 1.6.3. Secondary Sources & Third-Party Perspectives
- 1.6.4. Primary Research
- 1.6.5. Details of Primary Research
- 1.7. Information Analysis
- 1.7.1. Data Analysis Models
- 1.8. Market Formulation & Data Visualization
- 1.9. Data Validation & Publishing
- 1.10. Model Details
- 1.10.1. Commodity Flow Analysis
- 1.11. List of Abbreviations
- 1.12. List of Secondary Sources
- Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segmental Snapshot
- 2.3. Competitive Insights Snapshot
- Chapter 3. Market Variables, Trends, and Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Related/Ancillary Outlook
- 3.1.1.1. Legal Marijuana Market
- 3.2. Global Legal Cannabis Market - Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Growing adoption of medical marijuana for treatment of chronic diseases
- 3.2.1.2. Growing legalization of medical marijuana in various countries
- 3.2.1.3. Impending legalization of cannabis for recreational/adult use
- 3.2.1.4. Rising number of research studies on cannabis for various ailments
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. High pricing of medical marijuana, cannabis and CBD-based products
- 3.2.2.2. Lack of consistency in advertising policies regarding cannabis
- 3.3. Business Environment Analysis Tools: Global Legal Cannabis Market
- 3.3.1. Porter’s Five Forces Analysis
- 3.3.2. PESTLE Analysis
- 3.4. History of Medical Use of Cannabis Analysis
- 3.5. History of Industrial Use of Cannabis Analysis
- 3.6. Global Cannabis Legalization Timelines
- 3.7. Global Legal Cannabis Regulatory Scenario, By Country
- 3.7.1. U.S.
- 3.7.1.1. Overview
- 3.7.1.2. Cultivation
- 3.7.1.3. Regulatory Bodies/ Authorities Involved
- 3.7.2. Canada
- 3.7.2.1. Overview
- 3.7.2.2. Cultivation
- 3.7.2.3. Regulatory Bodies/ Authorities Involved
- 3.7.3. Germany
- 3.7.3.1. Overview
- 3.7.3.2. Cultivation
- 3.7.3.3. Regulatory Bodies/ Authorities Involved
- 3.7.4. Italy
- 3.7.4.1. Overview
- 3.7.4.2. Cultivation
- 3.7.4.3. Regulatory Bodies/ Authorities Involved
- 3.7.5. Netherlands
- 3.7.5.1. Overview
- 3.7.5.2. Cultivation
- 3.7.5.3. Regulatory Bodies/ Authorities Involved
- 3.7.6. Czech Republic
- 3.7.6.1. Overview
- 3.7.6.2. Cultivation
- 3.7.6.3. Regulatory Bodies/ Authorities Involved
- 3.7.7. Poland
- 3.7.7.1. Overview
- 3.7.7.2. Cultivation
- 3.7.7.3. Regulatory Bodies/ Authorities Involved
- 3.7.8. Switzerland
- 3.7.8.1. Overview
- 3.7.8.2. Cultivation
- 3.7.8.3. Regulatory Bodies/ Authorities Involved
- 3.7.9. Croatia
- 3.7.9.1. Overview
- 3.7.9.2. Cultivation
- 3.7.9.3. Regulatory Bodies/ Authorities Involved
- 3.7.10. Australia
- 3.7.10.1. Overview
- 3.7.10.2. Cultivation
- 3.7.10.3. Regulatory Bodies/ Authorities Involved
- 3.7.11. New Zealand
- 3.7.11.1. Overview
- 3.7.11.2. Cultivation
- 3.7.11.3. Regulatory Bodies/ Authorities Involved
- 3.7.12. Japan
- 3.7.12.1. Overview
- 3.7.12.2. Cultivation
- 3.7.12.3. Regulatory Bodies/ Authorities Involved
- 3.7.13. Thailand
- 3.7.13.1. Overview
- 3.7.13.2. Cultivation
- 3.7.13.3. Regulatory Bodies/ Authorities Involved
- 3.7.14. Uruguay
- 3.7.14.1. Overview
- 3.7.14.2. Cultivation
- 3.7.14.3. Regulatory Bodies/ Authorities Involved
- 3.7.15. Colombia
- 3.7.15.1. Overview
- 3.7.15.2. Cultivation
- 3.7.15.3. Regulatory Bodies/ Authorities Involved
- 3.7.16. Chile
- 3.7.16.1. Overview
- 3.7.16.2. Cultivation
- 3.7.16.3. Regulatory Bodies/ Authorities Involved
- 3.7.17. Mexico
- 3.7.17.1. Overview
- 3.7.17.2. Cultivation
- 3.7.17.3. Regulatory Bodies/ Authorities Involved
- 3.7.18. UK
- 3.7.18.1. Overview
- 3.7.18.2. Cultivation
- 3.7.18.3. Regulatory Bodies/ Authorities Involved
- 3.8. Global Legal Cannabis Regulatory Scenario, By Country
- 3.8.1. North America
- 3.8.2. Europe
- 3.8.3. Asia
- 3.8.4. Latin America
- 3.8.5. Middle East & Africa
- 3.9. Estimated Numbers Of Cannabis Users By Region Or Countries
- 3.10. Global Legal Cannabis Industry: Potential Trade Opportunity, By Region
- 3.10.1. North America
- 3.10.2. Europe
- 3.10.3. Asia
- 3.10.4. Latin America
- 3.10.5. Middle East & Africa
- 3.11. Global Legal Marijuana Trade Route
- 3.12. Global Hemp Trade Route
- 3.13. Countries Importing and Exporting Medical Cannabis (Flower)
- 3.14. Countries Importing and Exporting Hemp Seeds
- 3.15. Countries Importing and Exporting Hemp Seed oil
- 3.16. Global Legal Cannabis Industry: Seed to Shelf Story
- 3.16.1. Section Description
- 3.16.2. Cultivators and Growers
- 3.16.3. Manufacturers and Producers
- 3.16.4. Testers
- 3.16.5. Wholesalers and Distributors
- 3.16.6. Retailers
- 3.17. Global Legal Cannabis Industry: Supply Chain Analysis
- 3.17.1. Hemp Seed to CBD Consumer Health Products
- 3.17.2. Hemp Biomass to Industrial Applications
- 3.17.3. Marijuana Plant to Marijuana Oil
- 3.18. Generalized Guidelines and Requirements for Cannabis Cultivation
- 3.18.1. Outdoor Cultivation
- 3.18.2. Indoor Cultivation
- Chapter 4. Global Legal Cannabis Market: Source Estimates & Trend Analysis
- 4.1. Segment Definitions
- 4.2. Segment Dashboard
- 4.3. Global Legal Cannabis Market: Source Movement & Market Share Analysis, 2024 & 2033
- 4.4. Global Legal Cannabis Market Size & Trend Analysis, by Source, 2021 - 2033 (USD Million)
- 4.5. Marijuana
- 4.5.1. Marijuana Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.2. Flower Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.2.1. Flower Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.3. Oil and Tinctures Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.3.1. Oil and Tinctures Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6. Hemp
- 4.6.1. Hemp Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6.2. Hemp CBD Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6.2.1. Hemp CBD Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6.3. Industrial Hemp Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6.3.1. Industrial Hemp Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 5. Global Legal Cannabis Market: Derivative Estimates & Trend Analysis
- 5.1. Segment Definitions
- 5.2. Segment Dashboard
- 5.3. Global Legal Cannabis Market: Derivative Movement & Market Share Analysis, 2024 & 2033
- 5.4. Global Legal Cannabis Market Size & Trend Analysis, by Derivative, 2021 - 2033 (USD Million)
- 5.5. CBD
- 5.5.1. CBD Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.6. THC
- 5.6.1. THC Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.7. Others
- 5.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 6. Global Legal Cannabis Market: End-use Estimates & Trend Analysis
- 6.1. Segment Definitions
- 6.2. Segment Dashboard
- 6.3. Global Legal Cannabis Market: End-use Movement & Market Share Analysis, 2024 & 2033
- 6.4. Global Legal Cannabis Market Size & Trend Analysis, by End-use, 2021 - 2033 (USD Million)
- 6.5. Medical
- 6.5.1. Medical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.2. Cancer Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.2.1. Cancer Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.3. Chronic Pain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.3.1. Chronic Pain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.4. Depression and Anxiety Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.4.1. Depression and Anxiety Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.5. Arthritis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.5.1. Arthritis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.6. Diabetes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.6.1. Diabetes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.7. Glaucoma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.7.1. Glaucoma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.8. Migraines Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.8.1. Migraines Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.9. Epilepsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.9.1. Epilepsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.10. Multiple Sclerosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.10.1. Multiple Sclerosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.11. AIDS Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.11.1. AIDS Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.12. Amyotrophic Lateral Sclerosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.12.1. Amyotrophic Lateral Sclerosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.13. Alzheimer’s Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.13.1. Alzheimer’s Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.14. Post Traumatic Stress Disorder (PTSD)Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.14.1. Post Traumatic Stress Disorder (PTSD) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.15. Parkinson's Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.15.1. Parkinson's Market Estimates and Forecasts, 2021 - 2033(USD Million)
- 6.5.16. Tourette’s Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.16.1. Tourette’s Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.17. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.17.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6. Recreational
- 6.6.1. Recreational Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.7. Industrial
- 6.7.1. Industrial Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 7. Global Legal Cannabis Market: Regional Estimates & Trend Analysis
- 7.1. Legal Cannabis Market: Regional Movement Analysis, 2024 & 2033
- 7.2. North America
- 7.2.1. North America Legal Cannabis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.2.2. U.S.
- 7.2.2.1. Key Country Dynamics
- 7.2.2.2. Regulatory Framework
- 7.2.2.3. Competitive Scenario
- 7.2.2.4. U.S. Legal Cannabis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.2.3. Canada
- 7.2.3.1. Key Country Dynamics
- 7.2.3.2. Regulatory Framework
- 7.2.3.3. Competitive Scenario
- 7.2.3.4. Canada Legal Cannabis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.2.4. Mexico
- 7.2.4.1. Key Country Dynamics
- 7.2.4.2. Regulatory Framework
- 7.2.4.3. Competitive Scenario
- 7.2.4.4. Mexico Legal Cannabis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3. Europe
- 7.3.1. Europe Legal Cannabis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.2. UK
- 7.3.2.1. Key Country Dynamics
- 7.3.2.2. Regulatory Framework
- 7.3.2.3. Competitive Scenario
- 7.3.2.4. UK Legal Cannabis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.3. Germany
- 7.3.3.1. Key Country Dynamics
- 7.3.3.2. Regulatory Framework
- 7.3.3.3. Competitive Scenario
- 7.3.3.4. Germany Legal Cannabis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.4. Poland
- 7.3.4.1. Key Country Dynamics
- 7.3.4.2. Regulatory Framework
- 7.3.4.3. Competitive Scenario
- 7.3.4.4. France Legal Cannabis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.5. Italy
- 7.3.5.1. Key Country Dynamics
- 7.3.5.2. Regulatory Framework
- 7.3.5.3. Competitive Scenario
- 7.3.5.4. Italy Legal Cannabis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.6. Spain
- 7.3.6.1. Key Country Dynamics
- 7.3.6.2. Regulatory Framework
- 7.3.6.3. Competitive Scenario
- 7.3.6.4. Spain Legal Cannabis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.7. Czech Republic
- 7.3.7.1. Key Country Dynamics
- 7.3.7.2. Regulatory Framework
- 7.3.7.3. Competitive Scenario
- 7.3.7.4. Czech Republic Legal Cannabis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.8. Switzerland
- 7.3.8.1. Key Country Dynamics
- 7.3.8.2. Regulatory Framework
- 7.3.8.3. Competitive Scenario
- 7.3.8.4. Switzerland Legal Cannabis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.9. Croatia
- 7.3.9.1. Key Country Dynamics
- 7.3.9.2. Regulatory Framework
- 7.3.9.3. Competitive Scenario
- 7.3.9.4. Croatia Legal Cannabis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.10. Netherlands
- 7.3.10.1. Key Country Dynamics
- 7.3.10.2. Regulatory Framework
- 7.3.10.3. Competitive Scenario
- 7.3.10.4. Netherlands Legal Cannabis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4. Asia
- 7.4.1. Asia Legal Cannabis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.2. China
- 7.4.2.1. Key Country Dynamics
- 7.4.2.2. Regulatory Framework
- 7.4.2.3. Competitive Scenario
- 7.4.2.4. China Legal Cannabis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.3. Japan
- 7.4.3.1. Key Country Dynamics
- 7.4.3.2. Regulatory Framework
- 7.4.3.3. Competitive Scenario
- 7.4.3.4. Japan Legal Cannabis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.4. India
- 7.4.4.1. Key Country Dynamics
- 7.4.4.2. Regulatory Framework
- 7.4.4.3. Competitive Scenario
- 7.4.4.4. India Legal Cannabis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.5. Thailand
- 7.4.5.1. Key Country Dynamics
- 7.4.5.2. Regulatory Framework
- 7.4.5.3. Competitive Scenario
- 7.4.5.4. Thailand Legal Cannabis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5. Oceania
- 7.5.1. Oceania Legal Cannabis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.2. New Zealand
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Regulatory Framework
- 7.5.2.3. Competitive Scenario
- 7.5.2.4. New Zealand Legal Cannabis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.3. Australia
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Regulatory Framework
- 7.5.3.3. Competitive Scenario
- 7.5.3.4. Australia Legal Cannabis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6. Latin America
- 7.6.1. Latin America Legal Cannabis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.2. Brazil
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Regulatory Framework
- 7.6.2.3. Competitive Scenario
- 7.6.2.4. Brazil Legal Cannabis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.3. Uruguay
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Regulatory Framework
- 7.6.3.3. Competitive Scenario
- 7.6.3.4. Uruguay Legal Cannabis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.4. Colombia
- 7.6.4.1. Key Country Dynamics
- 7.6.4.2. Regulatory Framework
- 7.6.4.3. Competitive Scenario
- 7.6.4.4. Colombia Legal Cannabis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7. Africa
- 7.7.1. Africa Legal Cannabis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 8. Global Legal Cannabis Market: Competitive Analysis
- 8.1. Participant’s Categorization
- 8.2. Company Market Position Analysis, 2024
- 8.3. Strategy Mapping
- 8.4. Company Profiles/Listing
- 8.4.1. Tilray Brands
- 8.4.1.1. Overview
- 8.4.1.2. Financial Performance
- 8.4.1.3. Product Benchmarking
- 8.4.1.4. Strategic Initiatives
- 8.4.2. Canopy Growth Corporation
- 8.4.2.1. Overview
- 8.4.2.2. Financial Performance
- 8.4.2.3. Product Benchmarking
- 8.4.2.4. Strategic Initiatives
- 8.4.3. Aurora Cannabis, Inc.
- 8.4.3.1. Overview
- 8.4.3.2. Financial Performance
- 8.4.3.3. Product Benchmarking
- 8.4.3.4. Strategic Initiatives
- 8.4.4. Jazz Pharmaceuticals, Inc.
- 8.4.4.1. Overview
- 8.4.4.2. Financial Performance
- 8.4.4.3. Product Benchmarking
- 8.4.4.4. Strategic Initiatives
- 8.4.5. The Cronos Group
- 8.4.5.1. Overview
- 8.4.5.2. Financial Performance
- 8.4.5.3. Product Benchmarking
- 8.4.5.4. Strategic Initiatives
- 8.4.6. Organigram Holding, Inc.
- 8.4.6.1. Overview
- 8.4.6.2. Financial Performance
- 8.4.6.3. Product Benchmarking
- 8.4.6.4. Strategic Initiatives
- 8.4.7. Tikun Olam
- 8.4.7.1. Overview
- 8.4.7.2. Financial Performance
- 8.4.7.3. Product Benchmarking
- 8.4.7.4. Strategic Initiatives
- 8.4.8. ENDOCA
- 8.4.8.1. Overview
- 8.4.8.2. Financial Performance
- 8.4.8.3. Product Benchmarking
- 8.4.8.4. Strategic Initiatives
- 8.4.9. Isodiol International, Inc.
- 8.4.9.1. Overview
- 8.4.9.2. Financial Performance
- 8.4.9.3. Product Benchmarking
- 8.4.9.4. Strategic Initiatives
- 8.4.10. Medical Marijuana, Inc.
- 8.4.10.1. Overview
- 8.4.10.2. Financial Performance
- 8.4.10.3. Product Benchmarking
- 8.4.10.4. Strategic Initiatives
- 8.4.11. NuLeaf Naturals, LLC
- 8.4.11.1. Overview
- 8.4.11.2. Financial Performance
- 8.4.11.3. Product Benchmarking
- 8.4.11.4. Strategic Initiatives
- 8.4.12. Maricann Inc.
- 8.4.12.1. Overview
- 8.4.12.2. Financial Performance
- 8.4.12.3. Product Benchmarking
- 8.4.12.4. Strategic Initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.